Apr 27, 2022
1:25
For every 25 shares held, investors received 1. The price per share adjusted from $0.23 to $0.01.
The split itself did not change the total investment value.
InVivo Therapeutics Holdings Corporation (NVIV) trades on the NASDAQ Capital Market in the Biotechnology industry.
InVivo Therapeutics Holdings Corporation company overviewThe latest split shown was on April 27, 2022. It was a 1-for-25 reverse split, so shareholders received 1 share for every 25 they held.
This history records 4 reverse splits between April 8, 2015 and April 27, 2022.